| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Escherichia coli | 94 | 2025 | 962 | 14.590 |
Why?
|
| Escherichia coli Proteins | 54 | 2023 | 297 | 9.370 |
Why?
|
| DNA Repair | 49 | 2023 | 549 | 5.720 |
Why?
|
| Recombination, Genetic | 39 | 2023 | 418 | 3.890 |
Why?
|
| Mutagenesis | 31 | 2023 | 332 | 3.790 |
Why?
|
| DNA Damage | 23 | 2025 | 498 | 3.100 |
Why?
|
| Mutation | 48 | 2023 | 5941 | 2.880 |
Why?
|
| DNA Breaks, Double-Stranded | 17 | 2025 | 140 | 2.710 |
Why?
|
| Stress, Physiological | 13 | 2019 | 257 | 2.480 |
Why?
|
| DNA Replication | 17 | 2025 | 347 | 2.330 |
Why?
|
| Gene Expression Regulation, Bacterial | 14 | 2023 | 167 | 2.130 |
Why?
|
| DNA, Bacterial | 16 | 2019 | 482 | 2.000 |
Why?
|
| Evolution, Molecular | 17 | 2019 | 651 | 1.990 |
Why?
|
| Chromosomes, Bacterial | 13 | 2015 | 65 | 1.860 |
Why?
|
| Lac Operon | 18 | 2015 | 90 | 1.730 |
Why?
|
| Adaptation, Biological | 10 | 2019 | 32 | 1.600 |
Why?
|
| Bacterial Proteins | 29 | 2019 | 912 | 1.590 |
Why?
|
| Adaptation, Physiological | 13 | 2011 | 258 | 1.370 |
Why?
|
| Biological Evolution | 8 | 2013 | 222 | 1.270 |
Why?
|
| RecQ Helicases | 5 | 2019 | 62 | 1.230 |
Why?
|
| Models, Genetic | 23 | 2019 | 742 | 1.180 |
Why?
|
| DNA Helicases | 9 | 2023 | 229 | 1.130 |
Why?
|
| Exodeoxyribonucleases | 17 | 2011 | 50 | 1.110 |
Why?
|
| DNA, Cruciform | 5 | 2021 | 18 | 1.110 |
Why?
|
| Anti-Bacterial Agents | 7 | 2023 | 2507 | 1.100 |
Why?
|
| Sigma Factor | 9 | 2019 | 36 | 1.100 |
Why?
|
| Thymine | 3 | 2013 | 12 | 1.100 |
Why?
|
| DNA-Binding Proteins | 15 | 2023 | 1877 | 1.060 |
Why?
|
| Point Mutation | 10 | 2013 | 334 | 1.030 |
Why?
|
| Neoplasms | 7 | 2021 | 2855 | 1.000 |
Why?
|
| DNA Polymerase beta | 7 | 2010 | 15 | 0.990 |
Why?
|
| Frameshift Mutation | 11 | 2010 | 190 | 0.920 |
Why?
|
| Transcription Termination, Genetic | 1 | 2025 | 13 | 0.910 |
Why?
|
| DNA | 10 | 2023 | 1419 | 0.880 |
Why?
|
| Transcription, Genetic | 4 | 2025 | 1377 | 0.800 |
Why?
|
| Gene Amplification | 6 | 2012 | 227 | 0.780 |
Why?
|
| Acoustics | 1 | 2022 | 21 | 0.730 |
Why?
|
| Chromosome Fragile Sites | 1 | 2021 | 4 | 0.720 |
Why?
|
| Voice Quality | 1 | 2022 | 20 | 0.720 |
Why?
|
| Chromosome Fragility | 1 | 2021 | 13 | 0.710 |
Why?
|
| Bacteriophage mu | 2 | 2018 | 12 | 0.690 |
Why?
|
| DNA-Directed DNA Polymerase | 9 | 2019 | 85 | 0.660 |
Why?
|
| Rec A Recombinases | 9 | 2017 | 27 | 0.660 |
Why?
|
| Ciprofloxacin | 5 | 2023 | 64 | 0.650 |
Why?
|
| DNA Polymerase III | 6 | 2025 | 22 | 0.650 |
Why?
|
| Drug Resistance, Microbial | 5 | 2023 | 192 | 0.640 |
Why?
|
| Selection, Genetic | 7 | 2012 | 155 | 0.630 |
Why?
|
| Exodeoxyribonuclease V | 15 | 2017 | 23 | 0.620 |
Why?
|
| Genome, Bacterial | 6 | 2015 | 205 | 0.600 |
Why?
|
| Drug Resistance, Bacterial | 4 | 2022 | 381 | 0.590 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2018 | 37 | 0.580 |
Why?
|
| Genomic Instability | 6 | 2021 | 239 | 0.570 |
Why?
|
| Bacteria | 5 | 2019 | 502 | 0.570 |
Why?
|
| DNA, Single-Stranded | 5 | 2025 | 69 | 0.550 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 277 | 0.540 |
Why?
|
| Microbial Viability | 4 | 2016 | 42 | 0.530 |
Why?
|
| Fluorescent Dyes | 1 | 2018 | 245 | 0.530 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 2016 | 10 | 0.520 |
Why?
|
| RNA, Small Untranslated | 1 | 2016 | 20 | 0.520 |
Why?
|
| DNA Breaks, Single-Stranded | 1 | 2016 | 19 | 0.510 |
Why?
|
| Mutagens | 1 | 2016 | 48 | 0.510 |
Why?
|
| Nucleic Acid Heteroduplexes | 5 | 2013 | 17 | 0.490 |
Why?
|
| beta-Lactam Resistance | 2 | 2009 | 48 | 0.480 |
Why?
|
| Adenosine Triphosphatases | 6 | 2005 | 186 | 0.470 |
Why?
|
| DNA Breaks | 1 | 2015 | 25 | 0.460 |
Why?
|
| Membrane Transport Proteins | 2 | 2019 | 176 | 0.460 |
Why?
|
| DNA-Directed RNA Polymerases | 3 | 2025 | 75 | 0.450 |
Why?
|
| Repressor Proteins | 4 | 2015 | 761 | 0.440 |
Why?
|
| Cell Membrane | 1 | 2016 | 449 | 0.430 |
Why?
|
| DNA Replication Timing | 2 | 2011 | 11 | 0.430 |
Why?
|
| Transforming Growth Factor beta | 1 | 2017 | 445 | 0.430 |
Why?
|
| Protein Engineering | 1 | 2013 | 60 | 0.410 |
Why?
|
| Viral Proteins | 2 | 2013 | 335 | 0.380 |
Why?
|
| Genome | 3 | 2019 | 464 | 0.370 |
Why?
|
| Chromatin | 2 | 2013 | 472 | 0.370 |
Why?
|
| Transcription Factors | 5 | 2019 | 2337 | 0.360 |
Why?
|
| Clonal Evolution | 1 | 2011 | 46 | 0.360 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2013 | 679 | 0.360 |
Why?
|
| Chromosomes | 2 | 2023 | 118 | 0.360 |
Why?
|
| Loss of Heterozygosity | 1 | 2011 | 122 | 0.350 |
Why?
|
| Candida albicans | 1 | 2011 | 67 | 0.350 |
Why?
|
| RNA-Binding Proteins | 2 | 2022 | 533 | 0.350 |
Why?
|
| Gene Regulatory Networks | 1 | 2012 | 359 | 0.330 |
Why?
|
| Reactive Oxygen Species | 4 | 2022 | 493 | 0.320 |
Why?
|
| Base Sequence | 12 | 2007 | 2757 | 0.320 |
Why?
|
| Anti-Infective Agents | 1 | 2012 | 259 | 0.310 |
Why?
|
| Animals | 16 | 2024 | 33051 | 0.310 |
Why?
|
| Bacteriophage lambda | 5 | 1991 | 24 | 0.310 |
Why?
|
| Deinococcus | 1 | 2009 | 1 | 0.310 |
Why?
|
| Chromosome Aberrations | 1 | 2011 | 570 | 0.300 |
Why?
|
| Base Pair Mismatch | 4 | 2003 | 20 | 0.290 |
Why?
|
| Bacterial Toxins | 1 | 2009 | 171 | 0.290 |
Why?
|
| Endoribonucleases | 2 | 2024 | 84 | 0.290 |
Why?
|
| Molecular Sequence Data | 11 | 2006 | 3584 | 0.290 |
Why?
|
| Humans | 29 | 2025 | 126753 | 0.280 |
Why?
|
| Endodeoxyribonucleases | 5 | 2007 | 44 | 0.280 |
Why?
|
| Computational Biology | 1 | 2013 | 834 | 0.280 |
Why?
|
| Lung Neoplasms | 3 | 2024 | 1493 | 0.280 |
Why?
|
| Alleles | 6 | 2005 | 1609 | 0.280 |
Why?
|
| Serine Endopeptidases | 5 | 2013 | 191 | 0.260 |
Why?
|
| RNA | 2 | 2023 | 518 | 0.260 |
Why?
|
| DNA Copy Number Variations | 2 | 2012 | 1004 | 0.260 |
Why?
|
| Genes, Reporter | 5 | 2013 | 345 | 0.260 |
Why?
|
| Genome-Wide Association Study | 4 | 2024 | 1728 | 0.250 |
Why?
|
| Models, Biological | 6 | 2014 | 1370 | 0.240 |
Why?
|
| Sequence Deletion | 3 | 2001 | 510 | 0.230 |
Why?
|
| Plasmids | 5 | 2009 | 445 | 0.220 |
Why?
|
| Taxoids | 1 | 2024 | 70 | 0.220 |
Why?
|
| Heat-Shock Response | 1 | 2004 | 33 | 0.220 |
Why?
|
| RNA, Double-Stranded | 1 | 2024 | 59 | 0.220 |
Why?
|
| Pyroptosis | 1 | 2024 | 34 | 0.220 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 1758 | 0.220 |
Why?
|
| Gene Deletion | 5 | 2009 | 767 | 0.210 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 1995 | 348 | 0.210 |
Why?
|
| Genomics | 4 | 2021 | 1546 | 0.210 |
Why?
|
| Genes, Bacterial | 5 | 2006 | 215 | 0.210 |
Why?
|
| Operon | 1 | 2003 | 48 | 0.200 |
Why?
|
| Guanosine Tetraphosphate | 1 | 2023 | 6 | 0.200 |
Why?
|
| Caenorhabditis elegans | 1 | 2004 | 228 | 0.200 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2001 | 396 | 0.190 |
Why?
|
| Mutagenesis, Insertional | 2 | 2015 | 149 | 0.190 |
Why?
|
| Cosmic Radiation | 1 | 2022 | 14 | 0.190 |
Why?
|
| Pharmaceutical Preparations | 1 | 2023 | 80 | 0.190 |
Why?
|
| Radiation Protection | 1 | 2022 | 48 | 0.190 |
Why?
|
| Scandinavian and Nordic Countries | 1 | 2022 | 4 | 0.190 |
Why?
|
| Sound Spectrography | 1 | 2022 | 8 | 0.190 |
Why?
|
| Pitch Perception | 1 | 2022 | 5 | 0.180 |
Why?
|
| Phonation | 1 | 2022 | 6 | 0.180 |
Why?
|
| Singing | 1 | 2022 | 9 | 0.180 |
Why?
|
| Radiation Exposure | 1 | 2022 | 42 | 0.180 |
Why?
|
| Judgment | 1 | 2022 | 37 | 0.180 |
Why?
|
| Eukaryota | 1 | 2001 | 15 | 0.180 |
Why?
|
| Pressure | 1 | 2022 | 123 | 0.180 |
Why?
|
| Cell Division | 5 | 2019 | 720 | 0.170 |
Why?
|
| Temperature | 4 | 2007 | 284 | 0.170 |
Why?
|
| Fungi | 1 | 2001 | 58 | 0.170 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2024 | 267 | 0.170 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2023 | 276 | 0.170 |
Why?
|
| DNA Mutational Analysis | 3 | 2009 | 781 | 0.170 |
Why?
|
| DNA Polymerase II | 2 | 2010 | 19 | 0.160 |
Why?
|
| Transgenes | 1 | 2001 | 330 | 0.160 |
Why?
|
| Cloning, Molecular | 1 | 2001 | 784 | 0.160 |
Why?
|
| Regulon | 2 | 2015 | 9 | 0.160 |
Why?
|
| MutL Proteins | 4 | 2003 | 14 | 0.160 |
Why?
|
| Aging | 1 | 2007 | 1193 | 0.160 |
Why?
|
| beta-Lactamases | 1 | 2002 | 211 | 0.160 |
Why?
|
| Conjugation, Genetic | 2 | 1996 | 7 | 0.150 |
Why?
|
| Space Flight | 1 | 2022 | 166 | 0.150 |
Why?
|
| Phleomycins | 1 | 2018 | 6 | 0.150 |
Why?
|
| Phenotype | 5 | 2015 | 4304 | 0.150 |
Why?
|
| DNA, Viral | 4 | 1991 | 448 | 0.150 |
Why?
|
| Exonucleases | 1 | 2018 | 27 | 0.150 |
Why?
|
| Green Fluorescent Proteins | 2 | 2013 | 376 | 0.150 |
Why?
|
| Molecular Imaging | 1 | 2019 | 60 | 0.150 |
Why?
|
| Gene Dosage | 3 | 2016 | 436 | 0.140 |
Why?
|
| Lactose | 3 | 2004 | 53 | 0.140 |
Why?
|
| DNA Topoisomerases, Type I | 2 | 2010 | 22 | 0.140 |
Why?
|
| DNA Polymerase I | 2 | 2010 | 10 | 0.140 |
Why?
|
| Genetic Vectors | 1 | 2001 | 890 | 0.140 |
Why?
|
| CD24 Antigen | 1 | 2017 | 30 | 0.130 |
Why?
|
| Host Factor 1 Protein | 1 | 2016 | 2 | 0.130 |
Why?
|
| Hyaluronan Receptors | 1 | 2017 | 64 | 0.130 |
Why?
|
| Rad51 Recombinase | 1 | 2016 | 31 | 0.130 |
Why?
|
| Recombinases | 2 | 2011 | 27 | 0.130 |
Why?
|
| N-Acetylmuramoyl-L-alanine Amidase | 2 | 2009 | 6 | 0.130 |
Why?
|
| MutS DNA Mismatch-Binding Protein | 3 | 2003 | 6 | 0.120 |
Why?
|
| Holoenzymes | 1 | 2016 | 14 | 0.120 |
Why?
|
| DNA, Neoplasm | 1 | 2016 | 283 | 0.120 |
Why?
|
| Suppression, Genetic | 1 | 1995 | 41 | 0.120 |
Why?
|
| Mice | 4 | 2024 | 17596 | 0.110 |
Why?
|
| Gene Library | 1 | 2015 | 210 | 0.110 |
Why?
|
| Phosphates | 1 | 2015 | 108 | 0.110 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2015 | 117 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 3 | 2010 | 1204 | 0.110 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2014 | 39 | 0.110 |
Why?
|
| Tumor Suppressor p53-Binding Protein 1 | 1 | 2013 | 15 | 0.110 |
Why?
|
| Mutation, Missense | 2 | 2013 | 891 | 0.100 |
Why?
|
| Cytidine Deaminase | 1 | 2013 | 31 | 0.100 |
Why?
|
| Ku Autoantigen | 1 | 2013 | 21 | 0.100 |
Why?
|
| Synthetic Biology | 1 | 2013 | 14 | 0.100 |
Why?
|
| Ultraviolet Rays | 3 | 2004 | 191 | 0.100 |
Why?
|
| Biodiversity | 1 | 2014 | 73 | 0.100 |
Why?
|
| Transcriptome | 1 | 2019 | 1052 | 0.100 |
Why?
|
| Neovascularization, Pathologic | 1 | 2014 | 233 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2022 | 3262 | 0.100 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 652 | 0.100 |
Why?
|
| Epigenomics | 1 | 2013 | 173 | 0.090 |
Why?
|
| Protein Conformation | 1 | 2014 | 800 | 0.090 |
Why?
|
| HeLa Cells | 1 | 2013 | 684 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 634 | 0.090 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2011 | 14 | 0.090 |
Why?
|
| DNA Gyrase | 1 | 2011 | 25 | 0.090 |
Why?
|
| Biomarkers, Tumor | 1 | 2019 | 1560 | 0.090 |
Why?
|
| Genotype | 4 | 2015 | 2595 | 0.090 |
Why?
|
| Starvation | 1 | 2011 | 16 | 0.090 |
Why?
|
| F Factor | 2 | 2004 | 3 | 0.090 |
Why?
|
| Drug Design | 1 | 2012 | 153 | 0.090 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 686 | 0.090 |
Why?
|
| Culture Media | 1 | 2011 | 169 | 0.090 |
Why?
|
| Bacteriological Techniques | 1 | 2011 | 84 | 0.090 |
Why?
|
| Kinetics | 2 | 2004 | 1090 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 578 | 0.080 |
Why?
|
| Movement | 1 | 2011 | 143 | 0.080 |
Why?
|
| Flow Cytometry | 2 | 2016 | 754 | 0.080 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2011 | 191 | 0.080 |
Why?
|
| Genetic Variation | 1 | 2017 | 1508 | 0.080 |
Why?
|
| Chromosome Segregation | 1 | 2010 | 70 | 0.080 |
Why?
|
| Quantitative Trait Loci | 2 | 2022 | 290 | 0.080 |
Why?
|
| Genes, Essential | 1 | 2009 | 43 | 0.080 |
Why?
|
| DNA Transposable Elements | 1 | 2010 | 175 | 0.080 |
Why?
|
| Interphase | 2 | 1999 | 35 | 0.070 |
Why?
|
| Carbon | 1 | 2009 | 88 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 718 | 0.070 |
Why?
|
| Proteins | 1 | 2013 | 1018 | 0.070 |
Why?
|
| Interspersed Repetitive Sequences | 1 | 2007 | 25 | 0.070 |
Why?
|
| Young Adult | 1 | 2022 | 9665 | 0.070 |
Why?
|
| Oxidative Stress | 2 | 2003 | 756 | 0.070 |
Why?
|
| Time Factors | 3 | 2005 | 6134 | 0.070 |
Why?
|
| Proteome | 1 | 2009 | 273 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2009 | 1014 | 0.060 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 2 | 2005 | 48 | 0.060 |
Why?
|
| DNA Primers | 1 | 2007 | 602 | 0.060 |
Why?
|
| beta-Galactosidase | 2 | 1997 | 135 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2009 | 824 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2022 | 2746 | 0.060 |
Why?
|
| Lysogeny | 2 | 2001 | 9 | 0.060 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2007 | 748 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 2 | 2014 | 1707 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 2304 | 0.060 |
Why?
|
| Models, Animal | 1 | 2007 | 452 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2024 | 3498 | 0.060 |
Why?
|
| Bridged-Ring Compounds | 1 | 2024 | 19 | 0.060 |
Why?
|
| Escherichia coli K12 | 1 | 2004 | 3 | 0.060 |
Why?
|
| Binding, Competitive | 1 | 2004 | 153 | 0.060 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2024 | 122 | 0.050 |
Why?
|
| Smokers | 1 | 2024 | 37 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2010 | 4472 | 0.050 |
Why?
|
| Drug Resistance | 1 | 2004 | 246 | 0.050 |
Why?
|
| B7-H1 Antigen | 1 | 2024 | 125 | 0.050 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2005 | 260 | 0.050 |
Why?
|
| Geologic Sediments | 1 | 2003 | 8 | 0.050 |
Why?
|
| Air Microbiology | 1 | 2003 | 12 | 0.050 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2024 | 125 | 0.050 |
Why?
|
| Water Microbiology | 1 | 2003 | 25 | 0.050 |
Why?
|
| Thymidine | 1 | 2023 | 51 | 0.050 |
Why?
|
| Digestive System | 1 | 2003 | 61 | 0.050 |
Why?
|
| Xenopus Proteins | 1 | 2003 | 59 | 0.050 |
Why?
|
| Inflammasomes | 1 | 2024 | 148 | 0.050 |
Why?
|
| Moon | 1 | 2022 | 14 | 0.050 |
Why?
|
| Enterobacter | 1 | 2002 | 12 | 0.050 |
Why?
|
| Colistin | 1 | 2022 | 31 | 0.050 |
Why?
|
| beta-Lactams | 1 | 2002 | 57 | 0.050 |
Why?
|
| Attachment Sites, Microbiological | 1 | 2001 | 7 | 0.050 |
Why?
|
| Transformation, Genetic | 1 | 2001 | 29 | 0.040 |
Why?
|
| Middle Aged | 1 | 2022 | 27697 | 0.040 |
Why?
|
| Electroporation | 1 | 2001 | 35 | 0.040 |
Why?
|
| Virulence | 1 | 2001 | 263 | 0.040 |
Why?
|
| Adult | 1 | 2022 | 30410 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2007 | 531 | 0.040 |
Why?
|
| Sildenafil Citrate | 1 | 2001 | 57 | 0.040 |
Why?
|
| Salmonella | 1 | 2000 | 30 | 0.040 |
Why?
|
| Sulfones | 1 | 2001 | 70 | 0.040 |
Why?
|
| Blotting, Southern | 1 | 2000 | 207 | 0.040 |
Why?
|
| Purines | 1 | 2001 | 111 | 0.040 |
Why?
|
| Transduction, Genetic | 2 | 2005 | 283 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2023 | 551 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2003 | 665 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2003 | 538 | 0.040 |
Why?
|
| Transposases | 1 | 1999 | 40 | 0.040 |
Why?
|
| Research Design | 1 | 2024 | 691 | 0.040 |
Why?
|
| Piperazines | 1 | 2001 | 255 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2022 | 815 | 0.040 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1996 | 121 | 0.040 |
Why?
|
| Female | 2 | 2024 | 68330 | 0.040 |
Why?
|
| Smoking | 1 | 2024 | 901 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2001 | 466 | 0.040 |
Why?
|
| Chromosomal Instability | 1 | 2019 | 58 | 0.040 |
Why?
|
| Directed Molecular Evolution | 1 | 1998 | 11 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 2541 | 0.030 |
Why?
|
| Deoxyguanine Nucleotides | 1 | 2017 | 5 | 0.030 |
Why?
|
| Mitochondria | 1 | 2023 | 730 | 0.030 |
Why?
|
| Gene Expression | 1 | 2001 | 1482 | 0.030 |
Why?
|
| Lac Repressors | 1 | 1995 | 12 | 0.030 |
Why?
|
| Bacteriophage P1 | 1 | 2015 | 3 | 0.030 |
Why?
|
| Ethylnitrosourea | 1 | 2015 | 7 | 0.030 |
Why?
|
| Base Composition | 1 | 1995 | 71 | 0.030 |
Why?
|
| Crossing Over, Genetic | 1 | 1996 | 51 | 0.030 |
Why?
|
| Male | 1 | 2022 | 62543 | 0.030 |
Why?
|
| DNA, Fungal | 1 | 1996 | 70 | 0.030 |
Why?
|
| Methylation | 1 | 1996 | 196 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2016 | 291 | 0.030 |
Why?
|
| Protein Subunits | 1 | 2016 | 162 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2017 | 251 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2016 | 138 | 0.030 |
Why?
|
| Asymmetric Cell Division | 1 | 2014 | 8 | 0.030 |
Why?
|
| Oxygen | 1 | 2018 | 541 | 0.030 |
Why?
|
| Templates, Genetic | 1 | 1994 | 55 | 0.030 |
Why?
|
| Protein Binding | 1 | 2017 | 1661 | 0.030 |
Why?
|
| Ribonucleases | 1 | 2013 | 41 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 1995 | 252 | 0.020 |
Why?
|
| DNA End-Joining Repair | 1 | 2012 | 38 | 0.020 |
Why?
|
| Genes, Regulator | 1 | 1991 | 43 | 0.020 |
Why?
|
| Viral Structural Proteins | 1 | 1991 | 39 | 0.020 |
Why?
|
| Genes, Viral | 1 | 1991 | 156 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1991 | 146 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2012 | 321 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2013 | 565 | 0.020 |
Why?
|
| Algorithms | 1 | 2015 | 1633 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 1988 | 153 | 0.020 |
Why?
|
| Species Specificity | 1 | 1988 | 514 | 0.020 |
Why?
|
| Virus Replication | 2 | 1989 | 593 | 0.020 |
Why?
|
| DNA, Catenated | 1 | 2005 | 3 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2006 | 251 | 0.020 |
Why?
|
| DNA, Superhelical | 1 | 2005 | 23 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1985 | 297 | 0.010 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2004 | 44 | 0.010 |
Why?
|
| Morphogenesis | 1 | 1985 | 192 | 0.010 |
Why?
|
| Homeobox Protein Nkx-2.5 | 1 | 2003 | 18 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 307 | 0.010 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2003 | 90 | 0.010 |
Why?
|
| Spleen | 1 | 2003 | 253 | 0.010 |
Why?
|
| Stomach | 1 | 2003 | 267 | 0.010 |
Why?
|
| Gastric Mucosa | 1 | 2003 | 487 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2003 | 2310 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2003 | 1753 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1989 | 53 | 0.000 |
Why?
|
| Isotope Labeling | 1 | 1989 | 93 | 0.000 |
Why?
|